Back to News
Healthtech Thursday, February 26, 2026

YOU(th) Health raises $4.5M to put preventive screening on every smartphone

Berlin-based YOU(th) Health has closed a $4.5 million funding round to commercialise a smartphone-first approach to preventive healthcare.The seed-plus round was led by Callisto Health and joined by c…
YOU(th) Health raises $4.5M to put preventive screening on every smartphone

Berlin-based YOU(th) Health has closed a $4.5 million funding round to commercialise a smartphone-first approach to preventive healthcare.


The seed-plus round was led by Callisto Health and joined by caesar., adesso Ventures, Antler, Moonstone and 1024 Ventures, with angel checks from names including Alan founder Jean-Charles Samuelian and HomeToGo CEO Patrick Andrae.

The startup aims to remove the friction that keeps people from routine screening. YOU(th) says its platform can surface early risk signals in under two minutes by analysing face videos, voice, skin and eye images, typing patterns and step behaviour.


The system tracks more than 50 digital biomarkers across more than ten organ systems, from cardiovascular and respiratory to cognitive, skin and metabolic health.


"Our mission is to unlock prevention for 8 billion people. Everyone talks about prevention, yet only ~8% screen at the optimal frequency because time, cost, and friction get in the way," Filippo Nigro, founder and CEO of YOU(th), told TechInBerlin. "We remove those frictions by turning everyday phone behaviour, selfies, voice, typing, into passive health screening, seamlessly connected to real healthcare. Prevention shouldn’t interrupt life. It should run inside it."

YOU(th) is pursuing a B2B2C route, and has already signed more than 20 contracts with clinics and health insurance providers — evidence the startup is being taken seriously by incumbents that need scalable, low-cost screening. The new capital will be deployed to accelerate product delivery, with the majority earmarked for expanding engineering, data science and medical research teams.


That engineering-heavy allocation makes sense given the company's reliance on machine learning models and longitudinal digital biomarker datasets. YOU(th) also plans to deepen clinical validation and integrate predictive risk assessments with existing care pathways.


"We are happy to support the YOU(th) founders, as they solve a problem considered a hard fact by many: make relevant biomarkers accessible just through the technologies available in every smartphone and thereby enabling everyone to make more informed decisions," Stefan Eckhardt, Managing Director at Callisto Health, told TechInBerlin.


The founding team is explicitly international and technically deep. CEO Filippo Nigro is a TEDx speaker and a former product lead at HomeToGo. COO Johannes Kraus previously built a machine-learning marketplace for health insurers that was adopted by Munich Re. CTO Yuriy Dushin is a biostatistician and digital biomarker researcher with publications in Nature who leads the company’s scientific architecture.


"We have backed YOU(th) from the inception of the business because the team combines extraordinary technical depth with a clear vision for the future of longevity," Christoph Klink, Partner at Antler, told TechInBerlin. "They are building foundational infrastructure for preventive medicine that directly addresses the needs of an overstretched healthcare system."


YOU(th)’s approach sits at an increasingly crowded intersection: digital biomarkers, remote monitoring and consumer-first health. For Berlin founders and engineers, the startup is another signal that machine-learning-driven, smartphone-native health products can attract institutional capital and strategic insurer partners.


For investors, the thesis is clear but execution remains challenging: rigorous clinical validation, regulatory pathways, data privacy and integration into reimbursed care are the hurdles that determine whether a promising model becomes standard practice.


YOU(th) is betting that combining large, labelled digital-biomarker datasets with clinical partners will be enough to scale preventive screening without specialised hardware.


With $4.5 million in the bank and industry backers onboard, the next 12–18 months will be a test of product-market fit, validation speed and the company’s ability to turn passive signals into actionable, clinically useful insights.


Whether smartphones can become the everyday front door to prevention remains to be proven, but YOU(th)’s funding and traction make it one of Berlin’s startups to watch in digital health this year.